ARTICLE | Company News
Arexis, Biovitrum deal
August 29, 2005 7:00 AM UTC
Biovitrum acquired metabolic and inflammatory disease company Arexis for an undisclosed amount of cash and stock. Biovitrum develops compounds for obesity, diabetes and inflammation, and also is focus...